ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AZN Astrazeneca Plc

12,166.00
-6.00 (-0.05%)
16 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -6.00 -0.05% 12,166.00 12,132.00 12,136.00 12,198.00 12,076.00 12,180.00 1,644,408 16:35:22
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.59 188.1B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 12,172p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 12,432.00p.

Astrazeneca currently has 1,550,189,338 shares in issue. The market capitalisation of Astrazeneca is £188.10 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 31.59.

Astrazeneca Share Discussion Threads

Showing 3676 to 3697 of 6150 messages
Chat Pages: Latest  150  149  148  147  146  145  144  143  142  141  140  139  Older
DateSubjectAuthorDiscuss
31/12/2020
09:15
BBC News - AZ vaccine is now 1st choice, needing only one jab, given the viral vector, that gives 100% protection against hospitilisation.

IMVHO - as an investor couldn't give a stuff only interested in the core business which is evolving as planned.

beckers2008
31/12/2020
09:00
Many a great mistakes have been made in mergers and acquisitions by companies to me this up is one of them.I bet they have to go back with a higher offer.
montyhedge
31/12/2020
08:56
Analysts think they may have to pay more because the initial price seems to be a very good deal for AZN. Agree with EI that it is the size of the deal and execution risk that is taking the price down.
gary1966
31/12/2020
08:47
I dont think it's the price they are paying,

it's the size of the deal - if that makes sense.

A £10-15bn sized acquisition and the market would
have taken a more sanguine view.

essentialinvestor
31/12/2020
08:37
6700p I see for this, paying to much for Alexion.
montyhedge
30/12/2020
21:53
Share price down due to acquisition of Alexon at too high a price and some analysts said AZN might have to pay more to clinch the deal!??!!
thaiger
30/12/2020
19:35
The Astra vaccine is well ahead in the economic non mRNA vaccine for the masses race and will probably maintain pole position for some time to come given the not for profit during the pandemic strategy. This is just the beginning, the real benefits for AstraZeneca will be post pandemic.
bountyhunter
30/12/2020
19:30
The market cap is near £100 bn, a not for profit vaccine will make no
short term difference to the P&L. There may be a commercial benefit next year.

The parabolic run to over £100 a share was built on sand.

GSK is one of the largest and most successful vaccine manufacturers globally
and look at their 10 year share price.

There are 18 different vaccines in Phase 3 testing currently,
20 more in Phase 2.

The number of options available will keep prices and margins on this vaccine low imv.

essentialinvestor
30/12/2020
19:29
It will be a long term benefit post pandemic which will take a while to sink in for some 💉
bountyhunter
30/12/2020
19:26
Am a holder and I had no expectation of a rise. It was what was expected
davr0s
30/12/2020
19:17
You guys should not be investing as you don't understand what drives the SP
jock3636
30/12/2020
19:12
No idea. Release the best vaccine on the block share price falls. my Novartis shares are way up and this is down. Go figure.
bogman1
30/12/2020
18:41
So share price has dropped because...?
mariamw
30/12/2020
18:40
So why has the share price fallen this way.
mariamw
30/12/2020
17:54
After listening to the briefing it's obviously the Astra Zeneca is the game changer further world . Well done
beerboy02
30/12/2020
14:28
Quite a interesting read.https://fortune.com/2020/12/14/shareholders-adverse-reaction-astrazenecas-alexion-deal/
montyhedge
30/12/2020
14:15
Paying too little in my view, time will tell, this vaccine will be around for years with profits to be made once the pandemic is declared over. Quite likely an annual jab of this or a variant will be required as the virus is not likely to disappear as with the flu virus.
bountyhunter
30/12/2020
14:04
Brilliant for mankind, well done Astra, but it is this bid hedge funds are focused on. Paying to much in my view.
montyhedge
30/12/2020
13:54
AstraZeneca: ‘Winning’ vaccine formula is 100% effective against severe COVID-19
bountyhunter
30/12/2020
13:42
I see under 1000p when it all flops!
fission453
30/12/2020
13:17
Focus now on the bid, I think they are paying to much, shares diluted. I see under 7000p.
montyhedge
30/12/2020
13:05
Making big moves in the pre market across the Pond
donald t
Chat Pages: Latest  150  149  148  147  146  145  144  143  142  141  140  139  Older

Your Recent History

Delayed Upgrade Clock